Advancing Precision Molecular Discovery & Anti-Infective Therapeutics

Spatial Biologics Private Limited is an R&D biotechnology company dedicated to accelerating preclinical molecular therapeutics and computational drug discovery. We specialize in GPU-accelerated molecular dynamics simulations, structure-based virtual screening, quantum chemical calculations (DFT), and multi-omics bioinformatic pipelines.

Simultaneously, our translational programs focus on overcoming antimicrobial resistance (AMR) through rationally designed antimicrobial peptides and functional biomaterial formulations. By bridging predictive computational biophysics with empirical biological characterization, we empower academic scholars, biotechnology enterprises, and institutional research labs to transition seamlessly from molecular hypotheses to validated preclinical leads.

The Two Technology Pillars of Spatial Biologics

Spatial Biologics operates across two complementary technological engines, unifying predictive computational modeling with empirical biological characterization.

Proprietary Platform • In Development

Spatial Molecular Discovery Platform

A browser-accessible computational biology suite engineered to automate target preparation, molecular docking, molecular dynamics simulations, and predictive pharmacokinetics into reproducible research pipelines.

Target Curation Automated Workflows Cloud Infrastructure
Explore Molecular Platform
Preclinical R&D • VIT-TBI Incubated

Translational Anti-Infective Therapeutics

Preclinical R&D programs addressing antimicrobial resistance (AMR) and biofilm-forming pathogens through rationally designed antimicrobial peptides and functional biomaterial hydrogel formulations.

Biofilm Eradication Targeted Formulations Preclinical Leads
Discuss Collaborative R&D
Chat with us